New drug protects neurons in Parkinson's patients

September 5, 2012
New drug protects neurons in Parkinson's patients
The cognitins consist of two tacrine molecules connected by a flexible chain. Bis-3-cognitin (B3C) can protect neurons from damage in an animal model of Parkinson's.

(Medical Xpress)—Scientists at Emory University School of Medicine have identified a compound that boosts levels of a survival factor in neurons threatened by Parkinson's disease.

The compound, bis-3-cognitin, could be a starting point for finding drugs that delay Parkinson's . Bis-3-cognitin appears to protect mitochondria, critical sites of vulnerability for affected by Parkinson's.

In a widely used of Parkinson's, bis-3-cognitin could protect neurons from damaging toxins and prevent mice from developing motor problems when it was given together with the toxin. The results were published online August 13 by the .

Zixu Mao, professor of pharmacology and neurology at Emory University School of Medicine, and his colleagues had been studying MEF2D, a protein that is vital for the survival of neurons. The first author of the paper, graduate student Lu Yao, is now at Xi'an Jiaotong University in China. Collaborators include Yifan Han and his colleagues at Hong Kong Polytechnic University.

Mao's previous research had shown that MEF2D is perturbed in the neurons of people with Parkinson's disease. The MEF2D protein is sensitive to , such as oxidative stress, which can lead to neuron damage in Parkinson's.

"For years, we had been talking about looking for drugs that enhance MEF2D," Mao says. "The challenge was how to set up a . You can search through a library of small molecules, or you can look through the literature and make a guess."

Bis-3-cognitin appears to have been a good guess, even though it was originally developed for a different purpose. The cognitins are a family of compounds derived from tacrine, the first drug approved by the FDA to treat the symptoms of Alzheimer's disease. Tacrine was eventually discontinued because of and other side effects. The bis-cognitins have two tacrine molecules connected by a flexible chain (see figure).

Bis-3-cognitin could protect cells in culture against damage coming from the toxin MPTP, which mimics the effects of Parkinson's, by increasing MEF2D levels in the cells' nuclei and mitochondria. Tacrine and bis-7-cognitin, which has a longer connecting chain than bis-3-cognitin, did not have the same effects.

MPTP kills dopamine-responsive neurons, which are the same cells affected in Parkinson's. In mice, the scientists gauged the toxin's behavioral effects by measuring how long mice were able to hang on to a rotating rod, and studying their gait. Bis-3-cognitin, when given together with MPTP, could prevent motor impairment in the mice.

"We think MEF2D is not the only target of bis-3-cognitin," Mao says. "It is a potent antioxidant, for example. But MEF2D is required for the neuroprotective activity—we found that if you knock down MEF2D in cell lines, the protective effects are much weaker."

He adds that bis-3-cognitin appears to avoid the acute toxicity problems of tacrine, but more pharmacological studies of bis-3-cognitin's properties and mode of action are needed before human clinical trials.

Explore further: Therapeutic avenues for Parkinson's investigated at UH

More information: L. Yao et al. Activation of transcription factor MEF2 by bis(3)-cognitin protects dopaminergic neurons and ameliorates Parkinsonian motor defects. J. Biol Chem. (2012). www.jbc.org/cgi/doi/10.1074/jbc.M112.367540

Related Stories

Therapeutic avenues for Parkinson's investigated at UH

August 23, 2012
Scientists at the University of Houston (UH) have discovered what may possibly be a key ingredient in the fight against Parkinson's disease.

New hope for eyes damaged by Parkinson's disease

August 3, 2012
(Medical Xpress) -- Scientists have discovered a new avenue for the treatment of vision loss, one of the complications of Parkinson's disease.

Parkinson's disease: Study of live human neurons reveals the disease's genetic origins

February 7, 2012
Parkinson's disease researchers at the University at Buffalo have discovered how mutations in the parkin gene cause the disease, which afflicts at least 500,000 Americans and for which there is no cure.

Recommended for you

Singing may be good medicine for Parkinson's patients

August 11, 2017
(HealthDay)—Singing? To benefit people with Parkinson's disease? It just may help, a researcher says.

Tracing the path of Parkinson's disease proteins

August 4, 2017
As neurodegenerative disorders such as Parkinson's and Alzheimer's disease progress, misfolded proteins clump together in neurons, recruiting normal proteins in the cell to also misfold and aggregate. Cells in which this ...

Diabetes drug shows potential as disease-modifying therapy for Parkinson's disease

August 3, 2017
A drug commonly used to treat diabetes may have disease-modifying potential to treat Parkinson's disease, a new UCL-led study suggests, paving the way for further research to define its efficacy and safety.

Two new studies offer insights into gastrointestinal dysfunction in Parkinson's patients

July 31, 2017
Constipation is one of the most common non-motor related complaints affecting Parkinson's disease (PD) patients. Two important studies from the same research group published in the Journal of Parkinson's Disease expand the ...

New drug may treat and limit progression of Parkinson's disease

July 31, 2017
Researchers at Binghamton University have developed a new drug that may limit the progression of Parkinson's disease while providing better symptom relief to potentially hundreds of thousands of people with the disease.

A new insight into Parkinson's disease protein

July 28, 2017
Abnormal clumps of certain proteins in the brain are a prominent feature of Parkinson's and other neurodegenerative diseases, but the role those same proteins might play in the normal brain has been unknown.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.